Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05413564
Other study ID # LOCAL 2021 /AL
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 30, 2022
Est. completion date May 31, 2025

Study information

Verified date June 2022
Source Centre Hospitalier Universitaire de Nimes
Contact Amandine LUQUIENS, MD, PhD
Phone 0609566346
Email amandine.luquiens@chu-nimes.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Considering that self-exclusion from gambling on a particular website is an intervention for and by individuals who have developed a gambling disorder, it is currently exclusively a behavioural intervention in the sense that it prevents the behaviour Resumption of commercial solicitations only in the period when gambling is not accessible in the corresponding website , through voluntary self-exclusion (where the gambler prevents himself or herself from gambling), does not appear to be sufficient to prevent relapse. Early commercial solicitations, in the immediate intercourse after the end of the self-exlcusion period may precipitate relapse in gamblers whose behaviour change is by definition recent, and who have only received a behavioural measure. The investigators hypothesize an improved efficacy as measured by reduced gambling after a self-exclusion optimized by a period of suspension of commercial solicitations extended to 9 months, compared to self-exclusion with the standard procedure. Gamblers will be randomized according to an a priori randomization list.


Description:

This is a study evaluating the impact of PMU's implementation of an optimized self-exclusion procedure by extending the suspension of commercial solicitations for a total of 9 months, the self-exclusion being referred to as a non-medical "responsible gambling" tool, compared to the standard procedure. The self-excluded gamblers will be randomized according to an a priori randomization list, and will receive either the optimized self-exclusion procedure A or the standard self-exclusion procedure B. The study consists of a comparison between two groups A and B. The study involves non-medical gambling and socio-demographic data, routinely recorded in a regulatory manner with a permanent CNIL authorization PMU.


Recruitment information / eligibility

Status Recruiting
Enrollment 2554
Est. completion date May 31, 2025
Est. primary completion date March 30, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 99 Years
Eligibility Inclusion Criteria: - 18 years or older - self-excluder during the recruitment period - Online sports betting - poker and horse racing player - account opened for at least 4 weeks - self-exclusion for 3 months or less (minimum 3 days). Exclusion Criteria: - Player who has objected to the use of his collected data when opening his account. - It's not the first self-exclusion of the inclusion period.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
optimized self-exclusion procedure by extending the suspension of commercial solicitations for a total of 9 months
optimized self-exclusion procedure A

Locations

Country Name City State
France Amandine LUQUIENS Nîmes

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Nimes

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary change in total net loss Evaluate the effect of the self-exclusion procedure optimized by extending the suspension of commercial solicitations for a total of 9 months, compared to the existing procedure, on the intensity of gambling. over the last 4 weeks,between the last 4 weeks before self-exclusion T0, and the last 4 weeks at 9 months T2
Secondary change in total net loss Evaluate early efficacy at 6 months, maintenance of efficacy at 18 months comparison of changes according to type of play between last 4 weeks prior to self-exclusion, and last 4 weeks at 6 months T1, 12 months T3 and 18 months T4
See also
  Status Clinical Trial Phase
Recruiting NCT03614884 - Effectiveness of an Online Integrated Treatment for Problem Gambling and Tobacco Smoking N/A
Completed NCT03946098 - ICBTG in Routine Care N/A
Completed NCT03725735 - Emotion Regulation Group Treatment for Gambling Disorder - a Pilot Trial N/A
Not yet recruiting NCT05331612 - Blended Treatment for Problem Gambling and Gambling Disorder Combining Group Sessions and Online Modules N/A
Completed NCT03145792 - Online Coping Skills Counseling for Problem Gambling and Trauma N/A
Not yet recruiting NCT03280966 - Effects of Intranasal Naloxone on Gambling Urges in Gambling Disorder Phase 2
Recruiting NCT02953899 - Contingency Management as an Adjunct Treatment for Rural and Remote Disordered Gamblers N/A
Recruiting NCT05686772 - Prospective Multicenter Cohort Study Evaluating the Incidence and Risk Factors for Problem Gambling Among Young Adults With First-episode Psychosis
Recruiting NCT03336879 - Repetitive Transcranial Magnetic Stimulation in Gambling Disorder N/A
Recruiting NCT03669315 - Modulating Inhibitory Control Networks in Gambling Disorder With Theta Burst Stimulation Phase 3
Recruiting NCT05833503 - Integrative Couple Treatment for Gambling/Substance Use Disorder N/A
Completed NCT03477799 - The Effect of Transcranial Direct Current Stimulation on Decision Making and Cognitive Flexibility in Gambling Disorder Phase 3
Active, not recruiting NCT03497247 - Mindfulness-Based Cognitive-Behavioral Therapy for Gambling Disorder N/A
Recruiting NCT04646421 - Responsible Gambling Telephone Intervention to High-risk Gamblers by a State-owned Gambling Operator in Sweden.
Completed NCT03354702 - Physical Activity Pathological Gamblers N/A
Completed NCT03287583 - SBIRT Intervention for Gambling Behaviors N/A
Not yet recruiting NCT04158037 - Don't Go There: A Geospatial mHealth App for Gambling Disorder N/A
Not yet recruiting NCT06467422 - Effects of Transcranial Temporal Interference Stimulation on Risky Decision-making and Impulse Control in Gambling Disorder N/A
Not yet recruiting NCT04738773 - RCT for Gambling and Naltrexone, Using Use Eye-tracking Analysis to Predict Treatment Response Phase 2
Not yet recruiting NCT03493399 - Testing Interference-based Methods to Mitigate Gambling Craving - A Multiple Single Case Design N/A